Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.1185 per EA under NDC 62135089490. Its NADAC has been published 65 times since May 28, 2025.
FDA first approved this application on Jan 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
134 mg/1
Manufacturer
Chartwell RX LLCNDC
62135089490
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211407FDA Approved
1/31/2024
TE Code
AB
On Market Since
1/31/2024
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 65 times since May 28, 2025, and over the history we have for it it has declined 10.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1185 per EA |
|---|---|
| All-time high | $0.1391 (Sep 10, 2025) |
| All-time low | $0.1101 (Feb 18, 2026) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1219 |
| Average price | $0.1227 |
| Largest weekly change | -9.7% (Feb 18, 2026) |
| Weeks tracked | 65 |
| Tracking since | May 28, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.1185 per EA (NDC 62135089490), effective Aug 19, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 10.4%. It has been tracked across 65 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since May 28, 2025, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1101 (Feb 18, 2026) to a high of $0.1391 (Sep 10, 2025), with a median of $0.1219 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 134 MG CAPSULE, is $0.1089 per EA — about 8% below FENOFIBRATE 134 MG CAPSULE.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 62135089490) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.